Your browser doesn't support javascript.
loading
How health-related quality of life assessment should be used in advanced colorectal cancer clinical trials.
Bonnetain, F; Borg, C; Adams, R R; Ajani, J A; Benson, A; Bleiberg, H; Chibaudel, B; Diaz-Rubio, E; Douillard, J Y; Fuchs, C S; Giantonio, B J; Goldberg, R; Heinemann, V; Koopman, M; Labianca, R; Larsen, A K; Maughan, T; Mitchell, E; Peeters, M; Punt, C J A; Schmoll, H J; Tournigand, C; de Gramont, A.
Afiliación
  • Bonnetain F; Methodology and Quality of Life Unit, Oncology Department (INSERM UMR 1098), Quality of Life and Cancer Clinical Research Platform.
  • Borg C; Department of Medical Oncology, University Hospital of Besançon, Besançon.
  • Adams RR; Centre d'Investigation Clinique en Biothérapie, CIC-1431, Nantes.
  • Ajani JA; 11UMR1098 INSERM/Université de Franche Comté/Etablissement Français du Sang, Besançon.
  • Benson A; Department of Oncology, University Hospital of Besançon, Besançon, France.
  • Bleiberg H; Cardiff University and Velindre Cancer Centre, Cardiff, UK.
  • Chibaudel B; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston.
  • Diaz-Rubio E; Division of Hematology/Oncology, Northwestern Medical Group, Chicago, USA.
  • Douillard JY; Montagne de Saint Job, Brussels, Belgium.
  • Fuchs CS; Institut Hospitalier Franco-Britannique, Levallois-Perret, France.
  • Giantonio BJ; Medical Oncology Department, Hospital Clínico San Carlos, Madrid, Spain.
  • Goldberg R; Medical Oncology, Institut de Cancérologie de l'Ouest (ICO), Nantes St-Herblain, France.
  • Heinemann V; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston.
  • Koopman M; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia.
  • Labianca R; Department of Medicine, The Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute, Columbus, USA.
  • Larsen AK; Department of Internal Medicine III and Comprehensive Cancer Center, Klinikum Grosshadern, Ludwig-Maximilians-University of Munich, Munich, Germany.
  • Maughan T; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
  • Mitchell E; Cancer Center, Ospedale Giovanni XXIII, Bergamo, Italy.
  • Peeters M; Cancer Biology and Therapeutics, INSERM and Université Pierre et Marie Curie, Hôpital Saint-Antoine, Paris, France.
  • Punt CJA; CRUK/MRC Oxford Institute for Radiation Oncology, Gray Laboratories, University of Oxford, Oxford, UK.
  • Schmoll HJ; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, USA.
  • Tournigand C; Department of Oncology, Center for Oncological Research Antwerp, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium.
  • de Gramont A; Department of Medical Oncology, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands.
Ann Oncol ; 28(9): 2077-2085, 2017 Sep 01.
Article en En | MEDLINE | ID: mdl-28430862
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Colorrectales / Ensayos Clínicos como Asunto Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Neoplasias Colorrectales / Ensayos Clínicos como Asunto Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article